⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2746954 | 1.00 | — | — | |
| SCHEMBL31494789 | 1.00 | — | — | |
| SCHEMBL6514589 | 0.73 | — | — | |
| SCHEMBL4620545 | 0.73 | — | — | |
| SCHEMBL906464 | 0.71 | — | — | |
| SCHEMBL6155982 | 0.69 | — | — | |
| SCHEMBL8034630 | 0.69 | — | — | |
| SCHEMBL16248435 | 0.67 | — | — | |
| SCHEMBL17486920 | 0.67 | — | — | |
| SCHEMBL19275819 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684175-A | Preparation method of ethyl thioglycolate | 长沙贝塔医药科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119684175-B | Preparation method of ethyl thioglycolate | 长沙贝塔医药科技有限公司 | 2026-03-17 | — | — | CN | disclosed |
| CN-119684175-A | Preparation method of ethyl thioglycolate | 长沙贝塔医药科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119684175-A | Preparation method of ethyl thioglycolate | 长沙贝塔医药科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-1054887-B1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC (US) | 2006-04-12 | — | — | EP | disclosed |
| US-6583154-B1 | Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines | AMGEN INC. | 2003-06-24 | — | — | US | disclosed |
| US-6187777-B1 | PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS | AMGEN INC. | 2001-02-13 | — | — | US | disclosed |
| EP-1054887-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | Amgen Inc. (US) | 2000-11-29 | — | — | EP | disclosed |
| WO-1999040091-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC. (US) | 1999-08-12 | — | — | WO | disclosed |
| EP-0298543-B1 | THIAPENTANAMIDE DERIVATIVES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-09-29 | — | — | EP | disclosed |
| US-5153330-A | Thiapentanamide derivatives | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ, B.V. (NL) | 1992-10-06 | — | — | US | disclosed |
| EP-0298543-A2 | Thiapentanamide derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-01-11 | — | — | EP | disclosed |